Anti-BAFF treatment interferes with humoral responses in a model of renal transplantation in rats.
B cell activating factor (BAFF) is associated with donor-specific antibodies (DSA) and poorer outcomes after renal transplantation (RTx). We examined the effects of anti-BAFF treatment on B cells, expression of costimulatory molecules and cytokines, germinal centers (GCs) and DSA formation in a RTx model in rats. Anti-BAFF antibody was injected on days 3, 17, 31 and 45 after allogeneic RTx. Rats received reduced dose cyclosporine A (CsA) for 28 or 56 days to allow chronic rejection and DSA formation. Leukocytes, B cell subsets and DSA were measured using flow cytometry; expression of cytokines and costimulatory molecules was measured by qRT-PCR, and GCs and T follicular helper (TfH) were assessed using immunohistochemistry. Rejection was evaluated by a nephropathologist. Anti-BAFF treatment reduced the frequency of B cells in allografts and spleen. Naïve B cells were strongly reduced by anti-BAFF treatment in all compartments. mRNA expression of IL-6 and the costimulatory molecules CD40 and ICOS ligand was significantly reduced in anti-BAFF-treated rats. GCs were smaller and plasmablast/plasma cell numbers lower in anti-BAFF-treated rats, which was reflected by less DSA in certain IgG subclasses. Anti-BAFF treatment interferes with humoral responses at multiple levels in this model of allogeneic RTx.